Health In Tech Financials - Benzinga

Health In Tech Inc

HITNASDAQ

Trade with Public

Trade with Public

$0.8711

0.06117.54%

At close: Sep 18, 5:00 PM EST

$0.8537

-0.0174-2%

After Hours: 4:08 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Health In Tech Financials

Health In Tech (HIT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.813M Est

Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45.000 million-$50.000 million vs $46.813 million estimate.

Benzinga Newsdesk

PRO
Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate

Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 500 percent decrease over earnings of $0.01 per share from the

Benzinga Newsdesk

PRO
Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.528M Est

Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45.000 million-$50.000 million vs $46.528 million estimate.

Benzinga Newsdesk

PRO
Health In Tech Q1 EPS $(0.03), Inline, Sales $4.509M Miss $7.349M Estimate

Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 400 percent decrease over earnings of $0.01 per share from the same period last year. The

Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
Health In Tech Sees FY2026 Sales $45.000M-$50.000M vs $42.035M Est

Health In Tech (NASDAQ:HIT) sees FY2026 sales of $45.000 million-$50.000 million vs $42.035 million analyst estimate.

Benzinga Newsdesk